Immune Response of Haemodialysis Patients Post Covid-19 Vaccination
NCT ID: NCT04872751
Last Updated: 2021-05-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
425 participants
OBSERVATIONAL
2021-04-27
2022-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Observation of the Immune Response After COVID-19 Additional Vaccine Doses in Chronic Patients in Hemodialysis Therapy
NCT05142501
Assessment of Immune Response After Vaccination Against COVID-19 in Patients Treated With Renal Replacement Therapy
NCT04905862
RECOVAC - Long Term Efficacy and Safety of COVID-19 (SARS-CoV-2) Vaccination in Kidney Disease Patients
NCT04841785
The REnal Patients COVID-19 VACcination Immune Response (RECOVAC IR) Study
NCT04741386
Registry of Sustained Immunity to COVID-19 Among ESKD Patients
NCT04495764
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 18 years old and above
* consented to join the study
Exclusion Criteria
* patient who deemed unsuitable for Covid vaccination
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Penang Hospital, Malaysia
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr.Ong Loke Meng
Doctor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
LokeMeng Ong
Role: PRINCIPAL_INVESTIGATOR
Penang Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Penang Hospital
George Town, Pulau Pinang, Malaysia
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NMRR-21-634-59445
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.